Halberd Corp (HALB)

[pistol2]

BUSINESS DESCRIPTION
Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurological and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the specific disease, the treatment is applied to the bodily fluid extracorporeally, or outside the body. Disease eradication occurs when designed disease-specific antibodies conjoined with metallic nanoparticles come in contact with disease antigens, and the resultant conjoined antibody/nanoparticle/antigen moiety are then exposed to radio frequency, laser irradiation, or chemical bonding and are destroyed. The cleansed bodily fluids are then returned to the patient without deadly side effects associated with injected or ingested medications.Halberd's technology base consists of four issued patents and 22 pending patents: Projects with potential submission to government/military agencies include: * Extracorporeal eradication of inflammatory cytokines from cerebrospinal fluid associated with PTSD and Suicidal Ideation * Therapeutic lozenges to alleviate pain and anxiety as well as chemical and alcohol addiction * Eradication of antibiotic-resistant bacteria and deadly Candida Auris fungi supplied by CDC * Development of a nasal spray is in pre-clinical testing designed to eliminate neurodegenerative cascade associated of head trauma